Daniel A. Ermann
( out of 35 reviews )

Daniel A. Ermann, MD

  • Dr. Daniel Ermann joined the Division of Hematology/Hematologic malignancies in 2023 after completing his Hematology/Oncology fellowship at the Huntsman Cancer Institute of the University of Utah. He specializes in the treatment of patients with chronic lymphocytic leukemia (CLL) and other forms of Hodgkin and non-Hodgkin lymphoma, and he is passionate about working towards a cure for these malignancies. His research interests include the development and implementation of clinical trials, for which he is the principal investigator on multiple clinical trials at Huntsman Cancer Institute. He is also focused on outcomes research evaluating and improving on current standards of care across the spectrum of lymphoma management. Dr. Ermann is originally from Pennsylvania where he graduated from the University of Pittsburgh. He earned his medical degree from St. George’s University prior to completing his Internal Medicine residency training at Creighton University in Omaha, Nebraska.

    Specialties

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    5.0 /5
    ( out of 35 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

  • Dr. Daniel Ermann joined the Division of Hematology/Hematologic malignancies in 2023 after completing his Hematology/Oncology fellowship at the Huntsman Cancer Institute of the University of Utah. He specializes in the treatment of patients with chronic lymphocytic leukemia (CLL) and other forms of Hodgkin and non-Hodgkin lymphoma, and he is passionate about working towards a cure for these malignancies. His research interests include the development and implementation of clinical trials, for which he is the principal investigator on multiple clinical trials at Huntsman Cancer Institute. He is also focused on outcomes research evaluating and improving on current standards of care across the spectrum of lymphoma management. Dr. Ermann is originally from Pennsylvania where he graduated from the University of Pittsburgh. He earned his medical degree from St. George’s University prior to completing his Internal Medicine residency training at Creighton University in Omaha, Nebraska.

  • News & Podcasts

    Huntsman Cancer Institute News